Mar 7, 2019 Syros Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Multiple Upcoming Clinical Milestones for Its First-in-Class Programs
Feb 28, 2019 Syros to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 7, 2019
Feb 27, 2019 Syros to Present New Preclinical Data on Its Selective CDK7 Inhibitors, SY-1365 and SY-5609, at AACR Annual Meeting
Dec 2, 2018 Syros Announces Promising Clinical Data from Ongoing Phase 2 Trial of SY-1425 in Genomically Defined AML and MDS Patients at ASH Annual Meeting
